Dania Pagarkar joins Ethics Talk to discuss her article, coauthored with Drs Erin Harrop and Lisa Erlanger: “How Should We Approach Body Size Diversity in Clinical Trials?”
Isabelle M. Mikell joins Ethics Talk to discuss her article, coauthored with Courtney L. Savage Hoggard and Dr Harald Schmidt: "What Should Be Roles of Federal Clinician Governors in Motivating Equity in Locally Coordinated Triage Protocols?"
Eitan Neidich, Alon B. Neidich, David A. Axelrod, MD, and John P. Roberts, MD
Geographic disparities in availability of organs for transplant have spawned for-profit companies that help patients get on waitlists in more than one region and arrange travel for them if an organ becomes available.
In the same way that we learn about normal variations in blood pressure, we need to learn about “normal” variations in sexual interests and practices. We want to avoid clueless questions or unintentionally inflammatory statements.
Aaron Wightman, MD, MA and Douglas Diekema, MD, MPH
In making decisions about allocating scarce organs, undocumented immigrant status should not be used as a proxy for the legitimate criterion of likelihood of success because uncertainty about future ability to pay or insurance coverage applies to almost everyone listed for transplant.
AMA J Ethics. 2015;17(10):909-913. doi:
10.1001/journalofethics.2015.17.10.peer1-1510.